A new GLP-1 medication demonstrated efficacy in reducing blood sugar in people with type 2 diabetes in a phase 2b clinical trial
Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
Future Directions For GLP-1 Receptor Agonists Judging from the current research and development trends, long-acting, oral dosage forms and multi-target receptor agonists are the key directions for the future development of GLP-1 receptor agonists
The effectiveness of hydroxocobalamin was examined in a randomized, placebo-controlled, blinded study in cyanide-poisoned adult dogs assigned to treatment with vehicle (0.9% saline), or 75 or 150 mg/kg hydroxocobalamin
Adequate fluid intake helps manage constipation and supports overall digestive function
Increased energy and improved mobility were noted as successes, with certain participants experiencing significant advancements in their activity levels